These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27568889)

  • 21. Depression and Hypersomnia: A Complex Association.
    Lopez R; Barateau L; Evangelista E; Dauvilliers Y
    Sleep Med Clin; 2017 Sep; 12(3):395-405. PubMed ID: 28778237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excessive daytime sleepiness in adults with brain injuries.
    Masel BE; Scheibel RS; Kimbark T; Kuna ST
    Arch Phys Med Rehabil; 2001 Nov; 82(11):1526-32. PubMed ID: 11689971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is flumazenil an alternative for the treatment of hepatic encephalopathy?
    Reyes D; Barrera F
    Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin.
    Bassetti CL; Baumann CR; Dauvilliers Y; Croyal M; Robert P; Schwartz JC
    J Sleep Res; 2010 Dec; 19(4):620-3. PubMed ID: 20846244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System.
    Hulse G; Kelty E; Hood S; Norman A; Basso MR; Reece AS
    Curr Pharm Des; 2015; 21(23):3325-42. PubMed ID: 26088116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
    Puymirat J; Bouchard JP; Mathieu J
    Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examining the Frequency of Stimulant Misuse among Patients with Primary Disorders of Hypersomnolence: A Retrospective Cohort Study.
    Mantyh WG; Auger RR; Morgenthaler TI; Silber MH; Moore WR
    J Clin Sleep Med; 2016 May; 12(5):659-62. PubMed ID: 26943713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. French consensus. Hypersomnolence: Evaluation and diagnosis.
    Dauvilliers Y; Lopez R; Lecendreux M
    Rev Neurol (Paris); 2017; 173(1-2):19-24. PubMed ID: 27838094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flumazenil responsive ornithine transcarbamylase deficiency encephalopathy: clinical and radiographic features.
    Meyer MA; Gavrilova RH
    J Neuroimaging; 2002 Jan; 12(1):87-8. PubMed ID: 11826609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence.
    Urschel HC; Hanselka LL; Baron M
    J Psychopharmacol; 2011 Feb; 25(2):254-62. PubMed ID: 19939864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flumazenil-responsive stupor.
    Burdette DE
    Cephalalgia; 1998 Jan; 18(1):5-6. PubMed ID: 9601618
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM; Jensen TU; Emborg J
    Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.
    Maski K; Trotti LM; Kotagal S; Robert Auger R; Swick TJ; Rowley JA; Hashmi SD; Watson NF
    J Clin Sleep Med; 2021 Sep; 17(9):1895-1945. PubMed ID: 34743790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Idiopathic and recurrent stupor: efficacy of flumazenil].
    Lemesle M; Aube H; Madinier G; Manceau E; Wilkening M; Giroud M
    Presse Med; 1996 Nov; 25(37):1847. PubMed ID: 8991042
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypersomnia: Evaluation, Treatment, and Social and Economic Aspects.
    Saini P; Rye DB
    Sleep Med Clin; 2017 Mar; 12(1):47-60. PubMed ID: 28159097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Megadose bromazepam and zolpidem dependence: two case reports of treatment with flumazenil and valproate.
    Quaglio G; Faccini M; Vigneau CV; Casari R; Mathewson S; Licata M; Lugoboni F
    Subst Abus; 2012; 33(2):195-8. PubMed ID: 22489594
    [No Abstract]   [Full Text] [Related]  

  • 38. Cognitive effects of flumazenil in patients with Alzheimer's disease.
    Ott BR; Thompson JA; Whelihan WM
    J Clin Psychopharmacol; 1996 Oct; 16(5):400-2. PubMed ID: 8889914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Video NeuroImages: Idiopathic Recurring Stupor: An Unusual Clinical Condition Responding to Flumazenil.
    Gómez García A; Navas Vinagre I; Herranz Bárcenas A
    Neurology; 2021 Mar; 96(12):586. PubMed ID: 33441456
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.